![Report Japan - Medicaments of Antibiotics other than Penicillins, Streptomycins or their Derivatives - Market Analysis, Forecast, Size, Trends and Insights for 499$](/landing/img/reports/japan-medicaments-of-antibiotics-other-than-penicillins-streptomycins-or-their-derivatives-market-analysis-forecast-size-trends-and-insights.webp)
Japan - Medicaments of Antibiotics other than Penicillins, Streptomycins or their Derivatives - Market Analysis, Forecast, Size, Trends and Insights
Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.
View PricingJapan: Market for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives 2024
Market Size for Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Japan
The Japanese market for medicaments of antibiotics other than penicillins, streptomycins or their derivatives reduced to $X in 2023, falling by X% against the previous year. Over the period under review, consumption, however, continues to indicate a relatively flat trend pattern. As a result, consumption reached the peak level of $X. From 2021 to 2023, the growth of the market remained at a somewhat lower figure.
Production of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives in Japan
In value terms, non-penicillin or streptomycin antibiotic medicaments production shrank to $X in 2023 estimated in export price. Overall, production, however, saw a slight increase. The pace of growth was the most pronounced in 2020 when the production volume increased by X% against the previous year. As a result, production attained the peak level of $X. From 2021 to 2023, production growth remained at a somewhat lower figure.
Exports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives
Exports from Japan
In 2023, overseas shipments of medicaments of antibiotics other than penicillins, streptomycins or their derivatives increased by X% to X tons for the first time since 2020, thus ending a two-year declining trend. In general, exports, however, saw a pronounced decrease. Over the period under review, the exports hit record highs at X tons in 2018; however, from 2019 to 2023, the exports failed to regain momentum.
In value terms, non-penicillin or streptomycin antibiotic medicaments exports soared to $X in 2023. Overall, exports, however, saw a mild setback. Over the period under review, the exports attained the maximum at $X in 2020; however, from 2021 to 2023, the exports failed to regain momentum.
Exports by Country
China (X tons) was the main destination for non-penicillin or streptomycin antibiotic medicaments exports from Japan, accounting for a X% share of total exports. Moreover, non-penicillin or streptomycin antibiotic medicaments exports to China exceeded the volume sent to the second major destination, Taiwan (Chinese) (X tons), threefold. The third position in this ranking was held by Vietnam (X tons), with an X% share.
From 2012 to 2023, the average annual growth rate of volume to China stood at X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Taiwan (Chinese) (X% per year) and Vietnam (X% per year).
In value terms, China ($X) remains the key foreign market for medicaments of antibiotics other than penicillins, streptomycins or their derivatives exports from Japan, comprising X% of total exports. The second position in the ranking was taken by Taiwan (Chinese) ($X), with a X% share of total exports. It was followed by Italy, with a X% share.
From 2012 to 2023, the average annual rate of growth in terms of value to China amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Taiwan (Chinese) (X% per year) and Italy (X% per year).
Export Prices by Country
In 2023, the average export price for medicaments of antibiotics other than penicillins, streptomycins or their derivatives amounted to $X per ton, surging by X% against the previous year. Over the period under review, the export price showed a relatively flat trend pattern. The growth pace was the most rapid in 2020 an increase of X% against the previous year. As a result, the export price reached the peak level of $X per ton. From 2021 to 2023, the average export prices remained at a somewhat lower figure.
There were significant differences in the average prices for the major foreign markets. In 2023, amid the top suppliers, the country with the highest price was the Netherlands ($X,917 per ton), while the average price for exports to Vietnam ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was recorded for supplies to India (X%), while the prices for the other major destinations experienced more modest paces of growth.
Imports of Medicaments Of Antibiotics other than Penicillins, Streptomycins or their Derivatives
Imports into Japan
In 2023, approx. X tons of medicaments of antibiotics other than penicillins, streptomycins or their derivatives were imported into Japan; with a decrease of X% against 2022 figures. Over the period under review, imports, however, recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2016 with an increase of X% against the previous year. Imports peaked at X tons in 2019; however, from 2020 to 2023, imports remained at a lower figure.
In value terms, non-penicillin or streptomycin antibiotic medicaments imports declined to $X in 2023. In general, imports continue to indicate a abrupt setback. The pace of growth appeared the most rapid in 2019 with an increase of X% against the previous year. Imports peaked at $X in 2012; however, from 2013 to 2023, imports stood at a somewhat lower figure.
Imports by Country
China (X tons), South Korea (X tons) and Taiwan (Chinese) (X tons) were the main suppliers of non-penicillin or streptomycin antibiotic medicaments imports to Japan, together comprising X% of total imports. Thailand, Austria, the United States, Germany, the UK, Vietnam, Spain, Turkey, Canada and Norway lagged somewhat behind, together accounting for a further X%.
From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the main suppliers, was attained by Vietnam (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.
In value terms, the largest non-penicillin or streptomycin antibiotic medicaments suppliers to Japan were Canada ($X), South Korea ($X) and the United States ($X), together accounting for X% of total imports. Spain, Germany, China, Vietnam, Austria, Taiwan (Chinese), Thailand, Norway, the UK and Turkey lagged somewhat behind, together comprising a further X%.
Vietnam, with a CAGR of X%, recorded the highest growth rate of the value of imports, among the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.
Import Prices by Country
The average import price for medicaments of antibiotics other than penicillins, streptomycins or their derivatives stood at $X per ton in 2023, growing by X% against the previous year. Overall, the import price, however, saw a deep slump. Over the period under review, average import prices attained the maximum at $X per ton in 2012; however, from 2013 to 2023, import prices stood at a somewhat lower figure.
Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Canada ($X,156 per ton), while the price for China ($X per ton) was amongst the lowest.
From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Spain (X%), while the prices for the other major suppliers experienced mixed trend patterns.
Source: IndexBox Platform
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Japan. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Product coverage:
- Prodcom 21201150 - Medicaments of other antibiotics, n.p.r.s.
- Prodcom 21201180 - Medicaments of other antibiotics, p.r.s.
Country coverage:
- Japan
Data coverage:
- Market volume and value
- Per Capita consumption
- Forecast of the market dynamics in the medium term
- Trade (exports and imports) in Japan
- Export and import prices
- Market trends, drivers and restraints
- Key market players and their profiles
Reasons to buy this report:
- Take advantage of the latest data
- Find deeper insights into current market developments
- Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.
In this report, you can find information that helps you to make informed decisions on the following issues:
- How to diversify your business and benefit from new market opportunities
- How to load your idle production capacity
- How to boost your sales on overseas markets
- How to increase your profit margins
- How to make your supply chain more sustainable
- How to reduce your production and supply chain costs
- How to outsource production to other countries
- How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
-
1. INTRODUCTION
Making Data-Driven Decisions to Grow Your Business
- REPORT DESCRIPTION
- RESEARCH METHODOLOGY AND AI PLATFORM
- DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
- GLOSSARY AND SPECIFIC TERMS
-
2. EXECUTIVE SUMMARY
A Quick Overview of Market Performance
- KEY FINDINGS
- MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
-
3. MARKET OVERVIEW
Understanding the Current State of The Market and Its Prospects
- MARKET SIZE
- MARKET STRUCTURE
- TRADE BALANCE
- PER CAPITA CONSUMPTION
- MARKET FORECAST TO 2030
-
4. MOST PROMISING PRODUCT
Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO- TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
- BEST-SELLING PRODUCTS
- MOST CONSUMED PRODUCT
- MOST TRADED PRODUCT
- MOST PROFITABLE PRODUCT FOR EXPORT
-
5. MOST PROMISING SUPPLYING COUNTRIES
Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO- TOP COUNTRIES TO SOURCE YOUR PRODUCT
- TOP PRODUCING COUNTRIES
- TOP EXPORTING COUNTRIES
- LOW-COST EXPORTING COUNTRIES
-
6. MOST PROMISING OVERSEAS MARKETS
Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO- TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
- TOP CONSUMING MARKETS
- UNSATURATED MARKETS
- TOP IMPORTING MARKETS
- MOST PROFITABLE MARKETS
7. PRODUCTION
The Latest Trends and Insights into The Industry
- PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
- IMPORTS FROM 2012–2023
- IMPORTS BY COUNTRY
- IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
- EXPORTS FROM 2012–2023
- EXPORTS BY COUNTRY
- EXPORT PRICES BY COUNTRY
-
10. PROFILES OF MAJOR PRODUCERS
The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO -
LIST OF TABLES
- Key Findings In 2023
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Per Capita Consumption In 2012-2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
-
LIST OF FIGURES
- Market Volume, In Physical Terms, 2012–2023
- Market Value, 2012–2023
- Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
- Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
- Trade Balance, In Physical Terms, 2012-2023
- Trade Balance, In Value Terms, 2012-2023
- Per Capita Consumption, 2012-2023
- Market Volume Forecast to 2030
- Market Value Forecast to 2030
- Products: Market Size And Growth, By Type
- Products: Average Per Capita Consumption, By Type
- Products: Exports And Growth, By Type
- Products: Export Prices And Growth, By Type
- Production Volume And Growth
- Exports And Growth
- Export Prices And Growth
- Market Size And Growth
- Per Capita Consumption
- Imports And Growth
- Import Prices
- Production, In Physical Terms, 2012–2023
- Production, In Value Terms, 2012–2023
- Imports, In Physical Terms, 2012–2023
- Imports, In Value Terms, 2012–2023
- Imports, In Physical Terms, By Country, 2023
- Imports, In Physical Terms, By Country, 2012–2023
- Imports, In Value Terms, By Country, 2012–2023
- Import Prices, By Country Of Origin, 2012–2023
- Exports, In Physical Terms, 2012–2023
- Exports, In Value Terms, 2012–2023
- Exports, In Physical Terms, By Country, 2023
- Exports, In Physical Terms, By Country, 2012–2023
- Exports, In Value Terms, By Country, 2012–2023
- Export Prices, By Country Of Destination, 2012–2023
Recommended reports
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in Asia.
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in the U.S..
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in China.
This report provides an in-depth analysis of the market for non-penicillin or streptomycin antibiotic medicaments in the EU.
This report provides an in-depth analysis of the global market for non-penicillin or streptomycin antibiotic medicaments.
- Market Research in Japan
- Price for Medicaments of Other Antibiotics Japan
- Non-Penicillin or Streptomycin Antibiotic Medicaments Market
- Hormones Market
- Glycosides and Vegetable Alkaloids Market
- Antibiotic Market
- Organ Extracts Market
- Antisera Market
- Biological Product Market
- Sterile Medical Adhesion Barrier Market